Balchem Corporation
BCPC
$165.55
$1.000.61%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 964.54M | 953.68M | 942.38M | 932.39M | 929.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 964.54M | 953.68M | 942.38M | 932.39M | 929.56M |
| Cost of Revenue | 621.68M | 617.48M | 617.52M | 616.34M | 619.16M |
| Gross Profit | 342.86M | 336.21M | 324.86M | 316.05M | 310.40M |
| SG&A Expenses | 131.65M | 134.95M | 143.96M | 138.89M | 130.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 770.69M | 769.22M | 777.70M | 770.99M | 764.97M |
| Operating Income | 193.86M | 184.47M | 164.68M | 161.40M | 164.58M |
| Income Before Tax | 177.54M | 166.45M | 155.24M | 147.82M | 144.99M |
| Income Tax Expenses | 41.00M | 37.98M | 33.70M | 31.04M | 30.17M |
| Earnings from Continuing Operations | 136.54 | 128.48 | 121.54 | 116.78 | 114.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 136.54M | 128.48M | 121.54M | 116.78M | 114.82M |
| EBIT | 193.86M | 184.47M | 164.68M | 161.40M | 164.58M |
| EBITDA | 238.89M | 232.15M | 215.53M | 215.15M | 219.25M |
| EPS Basic | 4.21 | 3.97 | 3.76 | 3.62 | 3.56 |
| Normalized Basic EPS | 3.45 | 3.24 | 2.82 | 2.71 | 2.78 |
| EPS Diluted | 4.17 | 3.93 | 3.72 | 3.59 | 3.54 |
| Normalized Diluted EPS | 3.42 | 3.22 | 2.80 | 2.68 | 2.75 |
| Average Basic Shares Outstanding | 129.67M | 129.48M | 129.41M | 129.15M | 128.95M |
| Average Diluted Shares Outstanding | 130.79M | 130.61M | 130.54M | 130.23M | 130.01M |
| Dividend Per Share | 0.87 | 0.87 | 0.79 | 0.79 | 0.79 |
| Payout Ratio | 20.71% | 19.91% | 21.04% | 21.90% | 22.26% |